Leiomyosarcoma clinical trials at UC Cancer
3 research studies open to eligible people
A Study of Experimental Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (Mono)
open to all eligible people
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with Epstein-Barr virus (EBV) associated diseases.
at UC Davis UCLA
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
open to eligible people ages 18 years and up
This study will compare the efficacy and safety of unesbulin plus dacarbazine versus placebo plus dacarbazine in participants with unresectable or metastatic, relapsed or refractory LMS who have received at least 1 prior line of systemic therapy.
at UCLA
Phase 2 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
open to eligible people ages 12 years and up
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in solid tumors
at UCSF
Our lead scientists for Leiomyosarcoma research studies include Bartosz Chmielowski Brian Schulte, MD.
Last updated: